Immunic, Inc.
IMUX· Nasdaq
Released May 13, 2026, before the open
10-Q filed May 13, 2026, 43 days after period end · 0001280776-26-000010
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$32.59M | -$25.47M | -$29.58M | -$25.27M |
| EPS Diluted | -$1.08 | -$2.51 | -$0.30 | -$0.58 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR